At three months , the BBT group had a median reduction in daily beta 2-agonist dose of 904 micrograms ( range , 29 micrograms to 3129 micrograms ) , whereas the control group had a median reduction of 57 micrograms ( range , -2343 micrograms to 1143 micrograms ) ( P = 0.002 ) .
